Synthesis, spectroscopic and biological properties of bis(3- arylimidazolidinyl-1)methanes. A novel family of antimicrobial agents

European Journal of Medicinal Chemistry

Volumn 40, Issue 8, 2005, Pages 811-815

  Perillo, Isabel ^a   Repetto, Evangelina ^a   Caterina, María Cristina ^a   Massa, Rosana ^a   Gutkind, Gabriel ^a   Salerno, Alejandra ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aminals; Antimicrobial activity; Bis(3 arylimidazolidinyl 1)methanes; Imidazolidines

Indexed keywords

2 (2 CHLOROPHENYLAMINO) 1 METHYLENEAMINOETHANE; 2 (2 METHYLPHENYL) 1 METHYLENEAMINOMETHANE; 2 (2 NITROPHENYLAMINO) 1 METHYLENEAMINOETHANE; METHANE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; ETHYLENEDIAMINES; FORMALDEHYDE; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METHANE; MICROBIAL SENSITIVITY TESTS;

EID: 23944432963     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2005.03.010     Document Type: Article

References (25)

1. E. von Angerer, G. Kranzfelder, A.K. Tanejo, and H. Schonenberger J. Med. Chem. 23 1980 1347 1350
2. E. von Angerer, G. Egginger, G. Kranzfelder, H. Bernhauser, and H. Schonemberger J. Med. Chem. 25 1982 832 837
3. V. Sharma, and M.S.Y. Khan Eur. J. Med. Chem. 36 2001 651 658
4. a) W. E. Craig, J.O. Van Hook, U.S. 2675, 381, Chem. Abstr. 50 (1956) 411;
5. b) J.O. Van Hook, W.E. Craig, U.S. 2675, 387, Chem. Abstr. 49 (1955) 4729.
6. H.A. Nieper Arztl. Forsch. 20 1966 18 21
7. H.A. Schoenenberger, A. Adam, and D. Adam Arzneim Forsch. 16 1966 734 738
8. a) G. Crank, D.R. Harding, S.S. Szinai, J. Med. Chem. 13 (1970) 1212-1215;
9. b) G. Crank, D.R. Harding, S.S. Szinai, J. Med. Chem. 13 (1970) 1215-1217.
10. Among others: (a) C. Chapuis, A. Gauvreau, A. Klaebe, A. Lattes, J.J. Perie, Bull. Soc. Chim. France (1973) 977-985 and references therein;
11. b) A. Salerno, M.A. Figueroa, I.A. Perillo, Synth. Commun. 33 (2003) 3193-3204 and references therein.
12. a) L. Lázár, A. Göblyös, F. Evanics, G. Bernáth, F. Fülöp, Tetrahedron 54 (1998) 13639-13644;
13. b) A. Göblyös, L. Lázár, F. Evanics, F. Fülöp, Heterocycles 51 (1999) 2431-2438;
14. c) G. Parrinello, R. Mülhaupt, J. Org. Chem. 55 (1990) 1772-1779;
15. d) M. Boča, D. Valigura, W. Linert, Tetrahedron 56 (2000) 441-446.
16. a) H. Eggensperger, K.-H. Diehl, Ger. Offen. 2,635,389, Chem. Abstr. 88 (1978) 170125d;
17. b) W. Paulus, H. Genth, Ger. Offen 2,711,106, Chem. Abstr. 90 (1979) 230027 m.
18. I. Perillo, M.C. Caterina, J. Lopez, and A. Salerno Synthesis 6 2004 851 856
19. A. Salerno, G. Buldain, and I.A. Perillo J. Heterocyclic Chem. 38 2001 849 852
20. I.A. Perillo, C. de los Santos, and A. Salerno Heterocycles 60 2003 89 98
21. I.A. Perillo, G. Buldain, and A. Salerno Heterocycles 60 2003 2103 2113
22. M.K. Browne, G.B. Leslie, and R.W. Pfirrmann J. Appl. Bacteriol. 41 1976 363 368
23. P. Calabresi, F.A. Goulette, and J.W. Darnowsky Cancer Research 2001 6816 6821
24. C.B. Shah, M.W. Mittelman, J.H.W. Costerton, S. Pelak, R. Arsehault, and L.A. Mermel Antimicrob. Agents Chemother. 46 2002 1674 1679
25. J.H. Jorgensen, J.D. Turnidge, and J.A. Washington P. Murray E.J. Baron M.A. Pfaller F.C. Tenover R.H. Yolken Manual of Clinical Microbiology, seventh ed 1999 ASM Press Washington, DC 1526 1543